LG Chem is settling a trade secret violation suit against the SK Innovation and anticipates a resolution before October.
The US International Trade Commission (ITC) made a default judgment in favor of LG Chem in March, saying that SK Innovation had intentionally tampered evidence.
LG Chem accused SK Innovation of stealing trade secrets about lithium-ion batteries for electric vehicles by recruiting former LG Chem employees beginning 2017.
SK Innovation requested a review, and the ITC is expected to make a final decision in October.
An unfavorable decision against SK Innovation will force it to halt importing EV batteries, parts, and manufacturing equipment to the US.


California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability
Proposed Rio Tinto–Glencore Merger Faces China Regulatory Hurdles and Asset Sale Pressure
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10%
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 



